Arbor Medical Partners, LLC

Arbor Medical Partners, LLC was paid $12.71M by Medicaid between Jan 2018 and Dec 2024, across 80 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 28% of everything it billed.

33Billing provider infoARBOR MEDICAL PARTNERS, LLC
SCOTTSDALE, AZ 85258

33aNPI1023546082assigned 06/02/2017

33bProvider typePediatrics Physician

28Total paid$12.71M

24GClaims272,948

24DCodes billed80

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Pediatrics Physician providers in Arizona

Rank by total paid#5 of 235

Median peer was paid$164K

This provider vs. median78×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	25,282	$917K
2019	27,361	$971K
2020	27,530	$952K
2021	29,415	$1.29M
2022	39,076	$1.94M
2023	48,899	$2.59M
2024incomplete	75,385	$4.06M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	28%	67,029	63,139	$3.56M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	24%	42,426	40,220	$3.11M
90460	Immunization administration through 18 years of age via any route, first or only component	14%	43,316	42,262	$1.74M
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	9.2%	15,523	14,885	$1.16M
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	8.3%	13,443	13,194	$1.06M
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	7.4%	11,984	11,776	$945K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	4.3%	6,227	6,107	$543K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	7,274	6,955	$97K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	2,126	2,014	$70K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	3,130	3,060	$53K
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	2,169	2,095	$50K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	941	919	$41K

68 more codes

90461		<1%	940	$38K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	2,873	$36K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	1,070	$32K
99463		<1%	330	$27K
99384		<1%	151	$26K
0071A		<1%	247	$20K
96127		<1%	4,832	$18K
0072A		<1%	222	$18K
99215	Doctor's office visit, returning patient (complex)	<1%	152	$13K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	114	$10K
99173		<1%	5,855	$7K
99177		<1%	404	$7K
99381		<1%	56	$5K
90472	Immunization administration, each additional vaccine (list separately)	<1%	80	$3K
99460		<1%	49	$3K
99188		<1%	235	$3K
92551		<1%	1,054	$3K
87428		<1%	38	$3K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	44	$2K
99203	Doctor's office visit, new patient (routine)	<1%	24	$2K
94667		<1%	66	$1K
96161		<1%	497	$1K
99383		<1%	16	$1K
90670		<1%	6,712	$1K
90686		<1%	7,606	$1K
69210		<1%	27	$1K
83655		<1%	105	$1K
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	<1%	27	$989.58
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	142	$813.95
94010		<1%	34	$806.84
81002		<1%	281	$801.65
96160		<1%	295	$656.11
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	12	$373.91
96380		<1%	20	$332.54
85018		<1%	141	$278.34
94664		<1%	15	$263.06
S0119	Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code)	<1%	18	$234.15
86580		<1%	29	$234.00
90680		<1%	3,909	$194.89
99000		<1%	143	$149.86
90656		<1%	349	$145.31
90697		<1%	260	$122.50
90744		<1%	2,186	$103.56
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	12	$86.56
36415	Collection of venous blood by venipuncture	<1%	42	$79.50
90713		<1%	415	$56.04
90700		<1%	545	$50.10
90648		<1%	217	$44.34
90698		<1%	5,904	$20.28
94760		<1%	17	$15.62
36416		<1%	44	$6.94
90677		<1%	519	$1.99
3008F		<1%	904	$0.43
G9920	Screening performed and negative	<1%	69	$0.12
90633		<1%	2,161	$0.01
90651		<1%	773	$0.01
90621		0%	51	$0.00
90685		0%	404	$0.00
90710		0%	1,307	$0.00
90734		0%	79	$0.00
90715		0%	32	$0.00
90707		0%	115	$0.00
91307		0%	145	$0.00
90688		0%	1,613	$0.00
90696		0%	102	$0.00
90716		0%	114	$0.00
90619		0%	104	$0.00
90620		0%	12	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialZILTZER, VIVIAN (CEO/PRESIDENT)